371 related articles for article (PubMed ID: 12673735)
1. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma.
Chandler JD; Williams ED; Slavin JL; Best JD; Rogers S
Cancer; 2003 Apr; 97(8):2035-42. PubMed ID: 12673735
[TBL] [Abstract][Full Text] [Related]
2. Expression of GLUT12 in the fetal membranes of the human placenta.
Gude NM; Stevenson JL; Murthi P; Rogers S; Best JD; Kalionis B; King RG
Placenta; 2005 Jan; 26(1):67-72. PubMed ID: 15664413
[TBL] [Abstract][Full Text] [Related]
3. Expression and localisation of GLUT1 and GLUT12 glucose transporters in the pregnant and lactating rat mammary gland.
Macheda ML; Williams ED; Best JD; Wlodek ME; Rogers S
Cell Tissue Res; 2003 Jan; 311(1):91-7. PubMed ID: 12483288
[TBL] [Abstract][Full Text] [Related]
4. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
[TBL] [Abstract][Full Text] [Related]
5. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
[TBL] [Abstract][Full Text] [Related]
6. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
Monsef N; Soller M; Isaksson M; Abrahamsson PA; Panagopoulos I
Prostate; 2009 Jun; 69(9):909-16. PubMed ID: 19274762
[TBL] [Abstract][Full Text] [Related]
7. Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors.
Ciampi R; Vivaldi A; Romei C; Del Guerra A; Salvadori P; Cosci B; Pinchera A; Elisei R
Mol Cell Endocrinol; 2008 Sep; 291(1-2):57-62. PubMed ID: 18571834
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of facilitative glucose transporters GLUT1 and GLUT3 in the lens.
Merriman-Smith R; Donaldson P; Kistler J
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3224-30. PubMed ID: 10586946
[TBL] [Abstract][Full Text] [Related]
9. Expression, localization and activity of neutral endopeptidase in cultured cells of benign prostatic hyperplasia and prostate cancer.
Albrecht M; Gillen S; Wilhelm B; Doroszewicz J; Aumüller G
J Urol; 2002 Jul; 168(1):336-42. PubMed ID: 12050566
[TBL] [Abstract][Full Text] [Related]
10. Hexose transporter mRNAs for GLUT4, GLUT5, and GLUT12 predominate in human muscle.
Stuart CA; Yin D; Howell ME; Dykes RJ; Laffan JJ; Ferrando AA
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1067-73. PubMed ID: 16803853
[TBL] [Abstract][Full Text] [Related]
11. Glucose transporter 1 expression is enhanced during corneal epithelial wound repair.
Takahashi H; Kaminski AE; Zieske JD
Exp Eye Res; 1996 Dec; 63(6):649-59. PubMed ID: 9068372
[TBL] [Abstract][Full Text] [Related]
12. Human rhabdomyosarcoma cells retain insulin-regulated glucose transport activity through glucose transporter 1.
Ito S; Nemoto T; Satoh S; Sekihara H; Seyama Y; Kubota S
Arch Biochem Biophys; 2000 Jan; 373(1):72-82. PubMed ID: 10620325
[TBL] [Abstract][Full Text] [Related]
13. The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate.
Whittington K; Connors B; King K; Assinder S; Hogarth K; Nicholson H
Prostate; 2007 Jul; 67(10):1132-42. PubMed ID: 17492653
[TBL] [Abstract][Full Text] [Related]
14. Expression of basal cell keratins in human prostate cancer metastases and cell lines.
van Leenders GJ; Aalders TW; Hulsbergen-van de Kaa CA; Ruiter DJ; Schalken JA
J Pathol; 2001 Dec; 195(5):563-70. PubMed ID: 11745692
[TBL] [Abstract][Full Text] [Related]
15. Comparative gene and protein expression in primary cultures of epithelial cells from benign prostatic hyperplasia and prostate cancer.
Rose A; Xu Y; Chen Z; Fan Z; Stamey TA; McNeal JE; Caldwell M; Peehl DM
Cancer Lett; 2005 Sep; 227(2):213-22. PubMed ID: 16112424
[TBL] [Abstract][Full Text] [Related]
16. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.
Chen Q; Watson JT; Marengo SR; Decker KS; Coleman I; Nelson PS; Sikes RA
Cancer Lett; 2006 Dec; 244(2):274-88. PubMed ID: 16500022
[TBL] [Abstract][Full Text] [Related]
17. Ontogenetic profile and thyroid hormone regulation of type-1 and type-8 glucose transporters in rat Sertoli cells.
Carosa E; Radico C; Giansante N; Rossi S; D'Adamo F; Di Stasi SM; Lenzi A; Jannini EA
Int J Androl; 2005 Apr; 28(2):99-106. PubMed ID: 15811071
[TBL] [Abstract][Full Text] [Related]
18. Localization of the GLUT1 glucose transporter to brefeldin A-sensitive vesicles of differentiated CIT3 mouse mammary epithelial cells.
Haney PM
Cell Biol Int; 2001; 25(4):277-88. PubMed ID: 11319835
[TBL] [Abstract][Full Text] [Related]
19. Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma.
Effert P; Beniers AJ; Tamimi Y; Handt S; Jakse G
Anticancer Res; 2004; 24(5A):3057-63. PubMed ID: 15517916
[TBL] [Abstract][Full Text] [Related]
20. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
